Skip to Main Content

AANS/CNS Section on Tumors II

Wednesday, May 2 | 2:00 pm - 5:00 pm

Moderator(s): Steven N. Kalkanis, MD, FAANS; Rohan Ramakrishna, MD, FAANS

2:00 pm - 2:05 pm

Introduction to the Session: The Promise of Viral Oncolytic Therapy

Rohan Ramakrishna, MD, FAANS

2:06 pm - 2:22 pm

History and Potential Future Applications of Oncolytic Virus Therapy

Robert L. Martuza, MD, FAANS

2:23 pm - 2:39 pm

Oncolytic Adenoviruses: Clinical Trials and the Delivery Problem

Frederick F. Lang Jr., MD, FAANS

2:40 pm - 2:56 pm

Oncolytic Adenoviruses and Immunotherapy for Gliomas

Juan Fueyo, MD

2:57 pm - 3:13 pm

GBM Clinical Trials with Viral Based Gene Therapies: Resurrection of an Old Paradigm

E. Antonio Chiocca, MD, PhD, FAANS

3:14 pm - 3:30 pm

Oncolytic HSV and Immunotherapy for Adults and Children with Glioma

James M. Markert Jr., MD, FAANS

3:31 pm - 3:40 pm

759. Microglia-glioblastoma interactions influence clinical survival

Clark C. Chen, MD, PhD, FAANS

3:41 pm - 3:50 pm

760. Outcomes of Adoptive Cell Transfer with Tumor-Infiltrating Lymphocytes for Metastatic Melanoma Patients with and without Brain Metastases

Gautam Unmeel Mehta, MD

3:51 pm - 4:00 pm

761. Tumor-Induced Immunosuppression Promotes Brain Metastasis in Patients with Non-Small Cell Lung Cancer

Derek Li

4:01 pm - 4:10 pm

762. Activation of Canonical EGFR Pathway in Cushing’s Disease

Jacqueline Boyle

4:11 pm - 4:20 pm

763. Antitumor Efficacy Of Anti-PDL-1 In ACTH-Secreting Pituitary Adenomas: An Immunotherapeutic Approach For Cushing’s Disease

Hanna Kemeny

4:21 pm - 4:30 pm

764. Comparison of Intraoperative Imaging with Receptor-specific versus Passive Delivery of Near-Infrared Dyes in Human Pituitary Adenoma Surgery

Steve Cho

4:31 pm - 4:40 pm

765. Treatment response assessment maps (TRAMs): increased/decreased sensitivity to tumor/treatment-effects as a function of time post contrast injection

Yael Mardor, PhD (Israel)